foxo4-dri senolytic peptide human trials Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging Frontiers | Senolytic Peptide FOXO4-DRI

Works very good

This protocol makes the most sense for individuals who have already completed a cycle of semaglutide or tirzepatide and know they handle GLP-1 receptor activation without severe GI distress

However, the overall filling of the open wound to skin level with granulation tissue was significantly slower in the control group by 19 days compared to both the TCC group by 10 days and the zinc oxide group by 12 days, highlighting the positive impact of both active treatments on tissue regeneration [2]

Often called the healing peptide, BPC-157 acts as a potent anti-inflammatory agent designed to help you recover faster from injuries and chronic strain

However, regenerative epidural procedures are still being studied, and treatment standards continue to develop (Muthu et al., 2025

Imai S, Guarente L